Geneoscopy is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Geneoscopy develops noninvasive stool-based molecular diagnostic tests using RNA technology for colorectal cancer screening and gastrointestinal disease management.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.